Author:
Shimizu Kazuyuki,Kamiya Osamu,Hirabayashi Noriyuki,Ichikawa Atsushi,Kawashima Kohei,Kobayashi Masahide,Mizuno Harumitsu,Nagura Eiichi,Nitta Masakazu,Saito Hidehiko,Sao Hiroshi,Shibata Toshihiko,Takeyama Hideo,
Reference13 articles.
1. Is aggressive chemotherapy more effective in the treatment of plasma cell myeloma;Bergsagel;Eur. J. Cancer Clin. Oncol.,1989
2. Initial treatment in multiple myeloma: no advantage of multidrug chemotherapy over melphalan-prednisone;Hjorth;Br. J. Haematol.,1990
3. Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients;Boccadoro;J. Clin. Oncol.,1991
4. Proposed guidelines for protocol studies. II: Plasma cell myeloma;Chronic Leukemia-Myeloma Task Force.;Cancer Treat. Rep.,1973
5. Intensive treatment of multiple myeloma and criteria for complete remission;Gore;Lancet,1989